Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive...

43
Pharmacology of drugs affecting GIT

Transcript of Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive...

Page 1: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

Pharmacology of drugs affecting GIT

Page 2: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

Peptic Ulcer Disease Imbalance between mucosal defensive

factors and aggressive factors Major defensive – mucus and bicarbonate Major aggressive – gastric acid, H. pylori,

nonsteroidal anti-inflammatory drugs, pepsin

Page 3: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.
Page 4: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

Defensive factors Prevent the stomach and duodenum from being

harmed (self-digestion). Mucus – continually secreted, protective effect Bicarb – secreted from endothelial cells,

neutralized hydrogen ions Blood flow – good blood flow helps to maintain

mucosal integrity Prostaglandins – stimulate secretion of bicarb and

mucus and help promote blood flow, suppress secretion of gastric acid

Page 5: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

Aggressive factors Helicobacter pylori – gram negative

bacteria, can live in stomach and duodenum

May breakdown mucus layer, inflammatory response to presence of the bacteria may breakdown defenses, also produces urease – forms CO2 and ammonia which are toxic to mucosa

Page 6: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.
Page 7: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

PepsinSmoking

NSAIDS – inhibit the production of prostaglandins

Decrease blood flow, decrease mucus production and bicarb synthesis, promote gastric acid secretion

Gastric Acid – also needs to be present for ulcer to form – activates pepsin and injures mucosa

Page 8: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

Nondrug therapy Diet – change in eating pattern, 5-6 small

meals a day Smoking cessation, NSAID and ASA

should be avoided whenever possible, avoid alcohol

Page 9: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

Antibacterial drugs Combinations must be used Bismuth – disrupts cell wall of H. pylori,

pepto-bismol Clarithromycin – inhibits protein synthesis Amoxicillin – disrupts cell wall, good

when given with omeprazole Tetracyclin – inhibits protein synthesis Metronidazole – resistance,

Page 10: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

Histamine 2-receptor antagonists Suppress secretion of gastric acid (activation of

H2 receptors promotes secretion of gastric acid) Cimetidine - first available, oral, IV, IM May take up to twelve weeks for ulcer to be

healed Therapeutic uses – ulcers, GERD, Zollinger-

ellison syndrome, aspiration pneumonitis, heartburn, indigestion

Page 11: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.
Page 12: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.
Page 13: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

Proton Pump Inhibitors Suppress secretion of gastric acid Omeprazole – prilosec – prodrug that

converts to active form in parietal cells of stomach – inhibits enzyme that generates gastric acid

Ulcers, GERD, Zollinger-Ellison syndrome May contribute to development of gastric

tumors?

Page 14: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.
Page 15: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

Sucralfate Creates a protective barrier against acid

and pepsin Form sticky gel that coats ulcer portion Given every 6 hours Very few side effects – minimal systemic

absorption

Page 16: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

misoprostol Cytotec – prevention of gastric ulcers

caused by long-term NSAID therapy Replacement for endogenous

prostaglandins

Page 17: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

Antacids Peptic ulcers and GERD Neutralize acid Dosing – 7 times per day

Page 18: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

AlmagelCombined drug which contains gel of aluminum hydroxide, magnesium oxide and D-sorbit

170 ml bottles

Page 19: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

Schemes of combined treatment of gastric ulcer

De-nol + amoxycillin

De-nol + metronidazole

Omeprazole + amoxycillin + clarythromycin

De-nol + clarythromycin + metronidazole

De-nol + controlok + amoxycilin + clarythromycin

Page 20: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

Laxatives Laxative effect – production of a soft

formed stool over a period of 1 or more days

Catharsis – prompt, fluid evacuation of the bowel, more intense

Function of the colon – water and electrolyte absorption

Bowel evacuation – individual Dietary fiber

Page 21: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

Indications for laxative use Pain associated with bowel movements To decrease amount of strain under certain

conditions Evacuate bowel prior to procedures or

examinations Remove poisons To relieve constipation caused by

pregnancy or drugs

Page 22: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

Just because laxatives are available without a prescription doesn't mean that they're without risk.

Warning: Use of stimulant laxatives over a long period may lead to dependence and might permanently damage intestine and colon

Page 23: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

Classifications I – osmotic (high doses) II – osmotic (low doses), stimulant except

castor oil – most frequently abused III – bulk-forming, surfactant

Page 24: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

Bulk-forming Identical to fiber – soften fecal mass,

increasing bulk Temporary treatment of constipation,

preferred for patients with inflammatory bowel diseases

May help with diarrhea

Page 25: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

Adverse reactions Not absorbed – no systemic effects Must take with sufficient water Intestinal, esophageal obstruction Metamucil, citrucel

Page 26: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

Surfactant laxatives Bisacodyl, castor oil Stimulate intestinal motility Increase water and electrolytes in intestinal

lumen Produce stool within 6-12 hours

Page 27: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

Bisakodil

Page 28: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

Guttalax

Page 29: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

Miscellaneous laxatives Mineral oil Lactulose Glycerin suppository Polyethylene glycol-electrolyte solutions

Page 30: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

Laxative abuse Most common cause of constipation Teaching

Page 31: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

Choleretics of plant origin

Stigma of cornStigma of corn

Common immortelleCommon immortelle

Dog-roseDog-rose

Page 32: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

Tocopherole acetate (Tocopheroli acetas)Vitamin E is produced in many forms: 5 %, 10 % and 30 % oil solution in 10, 20 and 50 ml bottles; elastic

capsules with 0,1 and 0,2 ml of 50 % solution in oil; ampoules with 1 ml of 5 %, 10 % and 30 % oil solutions.

Page 33: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

Carsil Legalon

Page 34: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

Mechanism of action of legalon

Page 35: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

Essentiale Is produced in 5 ml ampoules and in capsules

Page 36: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

Lipostabil

Page 37: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

Pancreatin (Panсreatinum) Is produced in 0,25 g and 0,5 g dragee (tablets).

Page 38: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

Panzynorm forte

Page 39: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

Festal, Enzistal, Mezym-forte

Page 40: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

No-spa, nicospan

Page 41: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

Baralgin

Page 42: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

Bil-berries St. John’s wort

Page 43: Pharmacology of drugs affecting GIT. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and.

Pepper mint Chamomile